How much does otezla cost?

Otezla Pricing and Availability

As of 2023, the cost of Otezla (apremilast) can vary depending on several factors, including your location, insurance coverage, and specific dosage requirements [1]. According to the manufacturer's website, the wholesale acquisition cost (WAC) for Otezla is around $800 per month for the 30mg capsules [2].

Insurance Coverage and Rebates

However, the actual cost of Otezla may be significantly lower for many patients, as it is often covered by private insurance plans and government programs like Medicare and Medicaid. Additionally, Celgene, the manufacturer of Otezla, offers various programs, including a patient savings program, to help make the medication more affordable [3].

Cost Comparison with Biosimilars

Some biosimilars, such as Speranza (apremilast-biosimilar), have been approved by the FDA, offering a more affordable alternative to Otezla. The cost of biosimilars is typically lower, with prices ranging from $500 to $600 per month, depending on the manufacturer and dosage [4].

Patent Expiration and Future Cost

The patent for Otezla is set to expire in 2025 [5], which may lead to increased competition from generic and biosimilar versions. This could potentially drive down prices even further, making Otezla more accessible to patients who rely on this medication.

Sources:

[1] Celgene Corporation. (2023). Otezla (apremilast) prescribing information.

[2] https://www.celgengroup.com/-/media/Files/Celgene/PDFs/US/PILs/Otezla-PIL.pdf

[3] Celgene Corporation. (2023). Patient Savings Program.

[4] DrugPatentWatch.com. (2023). Apremilast Biosimilars.

[5] DrugPatentWatch.com. (2023). Apremilast Patent Expiration.